Raymond James analyst Dane Leone downgrades Galapagos (NASDAQ:GLPG) from Outperform to Market Perform.
Morgan Stanley Maintains Equal-Weight on Incyte, Raises Price Target to $77
Morgan Stanley analyst Vikram Purohit maintains Incyte (NASDAQ:INCY) with a Equal-Weight and raises the price target from $76 to $77.